Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of
Allosteric Site
Antifungal Agents
/ chemical synthesis
Azoles
/ chemical synthesis
Biofilms
/ drug effects
Candida albicans
/ drug effects
Candida parapsilosis
/ drug effects
Drug Resistance, Fungal
/ drug effects
Enzyme Inhibitors
/ chemical synthesis
Fructose-Bisphosphate Aldolase
/ antagonists & inhibitors
Fungal Proteins
/ antagonists & inhibitors
Microbial Sensitivity Tests
Molecular Structure
Protein Binding
Structure-Activity Relationship
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
10 02 2022
10 02 2022
Historique:
pubmed:
1
2
2022
medline:
19
2
2022
entrez:
31
1
2022
Statut:
ppublish
Résumé
Fructose-1,6-bisphosphate aldolase (FBA) represents an attractive new antifungal target. Here, we employed a structure-based optimization strategy to discover a novel covalent binding site (C292 site) and the first-in-class covalent allosteric inhibitors of FBA from
Identifiants
pubmed: 35099959
doi: 10.1021/acs.jmedchem.1c02102
doi:
Substances chimiques
Antifungal Agents
0
Azoles
0
Enzyme Inhibitors
0
Fungal Proteins
0
Fructose-Bisphosphate Aldolase
EC 4.1.2.13
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM